REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients

OBJECTIVES: This double-blind randomized controlled trial investigated raising serum 25-hydroxyvitamin D (25D) with extended-release calcifediol (ERC) on time to symptom resolution in patients with mild to moderate COVID-19. METHODS: COVID-19 outpatients received oral ERC (300 mcg on days 1–3 and 60...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Charles W., Ashfaq, Akhtar, Melnick, Joel Z., Vazquez-Escarpanter, Enrique, Fialkow, Jonathan A., Strugnell, Stephen A., Choe, John, Kalantar-Zadeh, Kamyar, Federman, Noah C., Ng, David, Adams, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OPKO Health. Published by Elsevier Inc. 2023
Materias:
Applied Nutritional Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639413/
https://www.ncbi.nlm.nih.gov/pubmed/36529089
http://dx.doi.org/10.1016/j.nut.2022.111899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639413/
https://www.ncbi.nlm.nih.gov/pubmed/36529089
http://dx.doi.org/10.1016/j.nut.2022.111899

Ejemplares similares